Metformin/Pioglitazone/Exenatide Triple Therapy Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed Type 2 Diabetes

Article Information

DOI 
http://dx.doi.org/10.1177/155989771311007
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Muriel Cunningham
  1. Muhammad Abdul-Ghani, MD, PhD
    1. University of Texas Health Science Center, San Antonio, Texas, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015300
Jun 2015100
Jul 2015100
Aug 2015111
Oct 2015233
Total1344

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Metformin/Pioglitazone/Exenatide Triple Therapy Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed Type 2 Diabetes
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Diabetes Mellitus
Diabetes & Endocrinology Clinical Trials
Diabetes Mellitus
Diabetes & Endocrinology Clinical Trials
Endocrinology
Diabetes & Metabolic Syndrome